MannKind | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
Adma Biologics USD 349.02M 117.13M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Insmed USD 285.38M 198.04M 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
MannKind USD -78816000 131.11M 2024-12
Merck USD 48.34B 2.02B 2025-03
Novo Nordisk DKK 120.52B 8B 2024-09
Pfizer USD 90.34B 2.14B 2025-03
Sanofi 74.07B 3.78B 2025-03
Xencor USD 677.61M 46.22M 2024-12



MannKind Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.